On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the ...
The recall includes certain bottles of lisdexamfetamine dimesylate capsules, a generic version of the ADHD medication Vyvanse ...
The Federal Circuit on Tuesday issued a precedential decision overturning a $39 million jury verdict finding that Sandoz Inc.
Several lots of the ADHD drug Lisdexamfetamine Dimesylate were recalled after failed dissolution tests, according to the FDA.
Meet Kevin on MSN
tesla's new car announcement
Reinvest AI & HouseHack Startup: (Read any solicitation paperwork before investing; investing involves risk - this video is not a solicitation). Life Insurance Sponsor: Affiliates and Paid Promotions ...
Current therapies such as biological DMARDs showed promising results in treating rheumatoid arthritis patients, and market penetration is expected to be more in the future and expected to drive market ...
Viehbacher, “Biogen”) announced today that humanized anti- soluble aggregated amyloid-beta (Aß) monoclonal antibody “LEQEMBI ® ” (generic name: lecanemab) has been approved for once every four weeks ...
Sun Pharmaceutical Industries has recalled several lots of lisdexamfetamine dimesylate capsules, a generic form of Vyvanse.The FDA classified the recall as Class II, indicating a low risk of serious ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...
Besmir Muslija, 40, Sacramento; 9:57 p.m. at Shenandoah Road east of Fiddletown Road in Plymouth: Misdemeanor DUI Alcohol, ...
Jesus Cruz Corral Sr., 67, Volcano; 1:42 p.m. at Highway 88 and Elliott Road in Lockeford: Felony Assault With A Deadly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback